News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Impact of dupilumab on children's quality of life and treatment-related anxiety identified - Hospital Healthcare Europe
The ways in which children and adolescents with severe asthma and/or moderate-to-severe atopic dermatitis perceive their medication and quality of life has been assessed in a real-world exploratory study, with particular focus on dupilumab.
Overcoming the reluctance to prescribe anticoagulants in older people with AF - Hospital Healthcare Europe
Anticoagulants have consistently been shown to reduce the risk of stroke for people with atrial fibrillation, but there may be a reluctance to prescribe these medications to older people due to concerns around adverse events and bleeding. Anneka Mitchell PhD, lead pharmacist for healthcare of older people and frailty at University Hospitals Plymouth NHS Trust and visiting postdoctoral researcher at the University of Bath, discusses recent research into the risks of stopping anticoagulation in this group.
Real-world evaluation of medication adherence in pulmonary hypertension - Hospital Healthcare Europe
Consistent adherence to pulmonary hypertension-specific oral therapy significantly improves clinical outcomes, according to a new prospective study evaluating patients with pulmonary arterial hypertension (PAH) and distal chronic thromboembolic pulmonary hypertension (CTEPH).
Prescribe ezetimibe with statins after myocardial infarction to improve prognosis, study suggests - Hospital Healthcare Europe
Early combination lipid-lowering therapy with statins and ezetimibe significantly improves prognosis after myocardial infarction compared with later adding ezetimibe or not giving it at all, a study finds.
Saliva test more accurate than PSA level or MRI for prostate cancer risk, study suggests - Hospital Healthcare Europe
An at-home saliva test that assesses genetic risk of prostate cancer is more accurate at detecting clinically significant disease than prostate-specific antigen (PSA) level or magnetic resonance imaging (MRI), UK researchers have reported.